Skip to main content
Caplight Logo









ReaGenics

ReaGenics

Private
Ness ZionaHealthcare & Life Scienceshttps://reagenics.com

Company Overview

ReaGenics operates in Healthcare & Life Sciences and is based in Ness Ziona. It was founded in 2019.

ReaGenics is a biotechnology company pioneering a novel plant cell bioreactor production for the mass-scale multiplication of molecules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ReaGenics Comparables

Compare ReaGenics with similar companies based on industry and business-model similarity.

ReaGenics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Novella Innovative Technology
87%
Ayana Bio
83%
Krokos Bio
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ReaGenics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for ReaGenics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Eran Lagon

Chief Executive Officer

Executive Team

Michael Kagan

Chief Executive Officer

Executive Team

Eliran Vanunu

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

ReaGenics Investors

Notable investors and investment history

ReaGenics investors
InvestorRounds
Israel Innovation AuthorityGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    Monthly visitors increased 34% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

ReaGenics Filings

Explore SEC and related filing metadata, where available.

ReaGenics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ReaGenics's valuation, stock price, and market status.

Is ReaGenics a public or private company?

ReaGenics is a private company.

What is the current stock price of ReaGenics?

ReaGenics is a private company, so its shares have no public market price. Caplight tracks ReaGenics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ReaGenics worth (valuation)?

Valuation information for ReaGenics is not publicly available.

Can I buy ReaGenics stock?

ReaGenics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ReaGenics's last funding round?

Funding round information for ReaGenics is not publicly available.

Who are the main investors in ReaGenics?

Key investors in ReaGenics include Israel Innovation Authority.

Will ReaGenics IPO soon?

No public IPO plans have been announced for ReaGenics.

How can I track ReaGenics secondary market activity?

Caplight tracks bids, offers, and trades in ReaGenics's shares on secondary markets.

Firmographic Details

HeadquartersNess Ziona
Employee Range6
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?